showed that the T-cell immunoglobulin domain and mucin domain-4 could inhibit the activation of PARK2 and reduce the secretion of TGF-β1 to alleviate liver fibrosis (58). This evidence concerns the gene TGFB1 and Hepatic fibrosis.